INTRODUCTION
Glaucoma is a heterogeneous group of optic neuropathies which manifest by optic nerve head cupping or degeneration of the optic nerve, resulting in a specific pattern of visual field loss (1 -3) . The disease affects 65 million people worldwide and is considered the second leading cause of blindness, accounting for 15% of cases (4) . It is sub-grouped into three major forms on the basis of etiology, anatomy of the anterior chamber and age of onset (2) . The three forms † Present address: Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.
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To whom correspondence should be addressed. Tel: þ98 9122181251 (E.E.)/þ44 2078373611 (C.P.R.); Fax: þ98 2166405141 (E.E.)/þ44 2078331016 (C.P.R.); Email: elaheelahi@ut.ac.ir (E.E.)/c.paisan-ruiz@ion.ucl.ac.uk (C.P. R.) are closed angle glaucoma, primary open angle glaucoma and primary congenital glaucoma (PCG). The subgroup PCG (OMIM 231300) is the most severe form of the disease. It is characterized by an anatomical defect of the trabecular meshwork (trabeculodysgenesis) and age of onset in the neonatal or infantile period, generally before the age of three (5) . The developmental anomaly at the angle of the anterior chamber manifests itself by increased intraocular pressure (IOP), corneal edema, excessive tearing, photophobia, enlargement of the globe (Buphthalmos) and opacity of the cornea. The details of the pathogenic pathways, including the relationship between elevated IOP and optic nerve damage, are not well understood. PCG occurs in both sporadic and familial patterns. In familial cases, inheritance is usually autosomal recessive. The incidence of PCG is geographically and ethnically variable, estimated at 1 : 10 000 in western countries and higher in inbred populations, for example 1 : 2500 in Saudi Arabia (5, 6) .
So far, three PCG loci have been identified by linkage analysis in multiply affected families, GLC3A (7), GLC3B (8) and GLC3C (5, 9) . The gene associated with GLC3A, CYP1B1 (OMIM 601771) which is a member of the cytochrome P450 superfamily of genes has been identified (10) . Although physiological studies have confirmed that mutations in CYP1B1 can cause disease, the pathway by which CYP1B1 affects development of the anterior chamber of the eye is unknown. In addition to CYP1B1, mutations in MYOC, a gene generally associated with early onset primary open angle glaucoma, have occasionally been reported in PCG patients (11, 12) . The proportion of PCG patients whose disease is due to CYP1B1 mutations is generally high, but varies among populations, ranging from 100% in Slovakia Roma to 20% in Japan (13, 14) . It has been observed that nearly 70% of Iranian PCG patients carry disease associated mutations in CYP1B1, and that 30% do not (15) .
In this report, we first perform autozygosity mapping in three Iranian PCG families and show that all affected individuals in two of the three families were homozygous in a region overlapping with the GLC3C locus on chromosome 14q24.2 -14q24.3 ( Fig. 1) (16) . We then report two disease-segregating mutations in the gene encoding the latent TGF-beta binding protein 2, LTBP2 (OMIM 602091) in manifesting individuals. We conclude that LTBP2 is a PCG causing gene. Ali and colleagues recently and independently reported null mutations in LTBP2 in PCG patients, and our results confirm their findings (17) .
RESULTS

Subjects
Clinical information on the affected individuals is presented in Table 1 . Notably, ectopia lentis was observed in both eyes of patient 23 and in the right eye of patient 13 of family A ( Fig. 2A and B) . Lens displacement could not be assessed in the left eye of 13 because of corneal clouding, and was absent in the unenucleated eye of patient 08. Patient 40 of family C did not exhibit lens displacement. Keratectasia (thinning of the cornea) was also observed in the left eye of 13 ( Fig. 2C) . A diffusely constricted visual field in left eye of 08, and nasal arcuate scotoma and central depression in the right eye of 13 and in both eyes of 23 were revealed by perimetry measurements (not shown). The arcuate scotoma may be indicative of optic nerve damage. (Fig. 1) .
Although there was only one affected individual in family C, it was considered that a homozygous genetic defect could also be the cause of the disease in this case as his parents were members of a small highly inbred village. Furthermore, they had the same ethnicity as family A. In fact, no autozygous segments were observed on the affected individual's chromosome 14; however, autozygous segments were identified on chromosomes 1 (not mapping to the GLC3B locus), 4, 6, 7, 8, 10, 13 and 17.
Gene screening
The critical region on chromosome 14 contains 40 annotated genes, and 28 open reading frames, pseudogenes and genes coding hypothetical proteins. Having selected candidate genes by 'in silico' analysis on the basis of functions and expression profiles, sequencing was initially carried out on DNA of affected individuals 07 and 21 in family A and 78 in family B. Sequence variations deemed to be possibly disease causing were not observed in ABCD4, ALDH6A1, ESSRB, TGFB3, TTLL5 and VSX2. Upon sequencing LTBP2, a homozygous deletion c.5376delC causing p.Tyr1793fsX55 and two known polymorphisms, rs862031 and rs61505039, were observed in LTBP2 in individuals 07 and 21 of family A (Fig. 3) . The novel c.5376delC deletion in exon 36 disrupts the C-terminal of the encoded protein, and creates an allele that encodes a protein 28 amino acids longer that the wild-type LTBP2. Subsequently, this deletion was shown by sequencing to be present in homozygous state in all available DNAs of affected individuals of family A and absent or present in heterozygous Affected eye (Fig. 1 ). While sequencing LTBP2 in patient 78 of family B, a homozygous deletion c.1415delC in exon 7 causing p.Ser472fsX3, a novel silent variation c.1287G.A resulting in p.Leu429Leu, and two additional known polymorphisms, rs2304707 and rs862031, were observed ( Fig. 3) . The c.1415delC deletion was shown to also be present in the homozygous state in the second manifesting individual (79) of family B, and absent or present in the heterozygous state in all non-affected individuals of this family, again suggesting segregation with disease ( Fig. 1 ). Both novel LTBP2 deletions were absent in 400 control individuals (data not shown). In conclusion, it was summarized that LTBP2 is the disease causing gene in families A and B.
The possibility that the isolated patient 40 in family C harbors compound heterozygous mutations in LTBP2 was given consideration. Sequencing of all LTBP2 exons in these individual revealed two novel nucleotide variations affecting amino acid changes, c.2966C.G in exon 19 causing p.Pro989Arg and c.4808G.A in exon 33 causing p.Arg1603His. Inheritance of the variations was consistent with disease-segregation (Fig. 1) . Proline (Pro) at position 989 of human LTBP2 is well conserved and only infrequently observed changed to other non-polar amino acids leucine or alanine in other species (Supplementary Material, Table S1 ). Surprisingly, the c.2966C.G variation was observed in the heterozygous state in 3 of the 400 control individuals screened. It was therefore considered most likely to be a variation not associated with PCG. Arginine at residue 1603 of human LTBP2 is less conserved and observed changed to histidine in several other species (Supplementary Material, Table S1 ). However, histidine was not observed in 400 control individuals from Iran. These findings make it unclear whether the missense variations can cause PCG. One may speculate that p.Pro989Arg is pathogenic and the three controls harboring it were carriers of the mutation. Similarly, it is possible that histidine at position 1603 is a loss of function mutation in human beings. Alternatively, both variations may be non-disease associated polymorphisms. None of the nucleotide variations observed in individual 40 were predicted to affect splicing.
Expression analysis
Transcription of LTBP2 was shown by real time polymerase chain reaction (PCR) in two primary human trabecular meshwork cell lines (Fig. 4) . Level of transcription of LTBP2 was shown to be, respectively, 12.7 and 0.6 times that of FOXC1 and CYP1B1, genes known to be expressed at relatively high levels in the trabecular meshwork (10, 18) . Finally, expression of the protein was demonstrated by immunological reactions in histological sections prepared from human eye globes (Fig. 5) . Expression of LTBP2 in the sections was highest in Descemet's membrane/endothelium layer and in the lens capsule/lens epithelium layer. It was also observed in the non-pigmented epithelium of the ciliary processes, the trabecular meshwork and the transitional zone between the sclera and the corneal stroma. Expression was minimal in the corneal stroma, sclera and iris. Segregation of the deletion variations with disease status, inclusion in a locus observed in Pakistani PCG patients, and expression in the human eye, particularly in the trabecular meshwork and ciliary processes which are thought to be involved in the etiology of PCG, allowed us to surmise that LTBP2 is the PCG causing gene in families A and B.
DISCUSSION
Here, we provide genetic evidence that LTBP2 mutations cause PCG. While this manuscript was in preparation, the observation of null mutations in LTBP2 that cause PCG in Pakistani patients was reported by other scientists (17) . We showed by genome wide autozygosity mapping in two unrelated consanguineous Iranian families that PCG maps to a 4.55 Mb locus on chromosome 14. We then identified two novel, loss of function mutations segregating with disease status in two unrelated PCG families in the gene encoding latent TGF-beta binding protein 2, LTBP2. Each mutation segregated with disease status in the respective family and both were absent in 400 control individuals. All mutation-bearing chromosomes in pedigree A were identical by descent, despite the fact that the structure of the pedigree seems not to make this point unequivocal. On the one hand, the pedigree is highly inbred; some individuals definitively reported consanguinity and others (for example, the parents of affected person 04) wavered in this regard. (Consanguinity is indicated in Figure 1 only when this relationship was unambiguously reported.) Furthermore, all individuals bearing the mutation shared a common haplotype as defined by the more that 500 SNPs in the autozygous region on chromosome 14. As already stated, this haplotype was distinctly different from the haplotype associated with the c.1415delC mutation in family B. In addition, an isolated PCG case was identified to be a carrier of compound heterozygous LTBP2 variations causing amino acid changes. However, the pathogenic role of these missense variants, p.Pro989Arg and p.Arg1603His, remain unclear as one of them, p.Pro989Arg, was identified 
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Human Molecular Genetics, 2009, Vol. 18, No. 20 in 3 out of 400 controls analyzed. One may speculate that p.Pro989Arg is pathogenic and the three controls harboring it were random mutation carriers. As our two definitive PCG associated mutations in LTBP2 and the PCG associated mutations reported in the earlier publication are all null mutations, the observation of these missense mutations is intriguing (17) . Further reports regarding LTBP2 mutations are warranted to investigate whether missense mutations may also cause PCG. Missense mutations may delineate regions of the LTBP2 protein that critically affect its function. Finally, we showed LTBP2 expression in parts of the human eye, including the trabecular meshwork and ciliary processes which are thought to be involved in the etiology of PCG. The results attest both to the power of high density chips and autozygosity mapping (19 -21) . They further confirm the role of LTBP2 in causing PCG (17) . Previously, PCG had been linked to chromosome 14 by linkage analysis using microsatellite markers in two reports published in 2002 and 2008. The 2008 publication reported overlapping linked regions in two Pakistani families, and mutation screening in the overlapping region ultimately led to identification of LTBP2 as causative of PCG (17) . The linked region of only one of the Pakistani families overlapped with the GLC3C locus reported in 2002 (Fig. 6) . The locus identified in the Iranian families overlap with parts of regions identified in both previous studies (Fig. 6) . LTBP2 lies within the linked region of the Pakistani and Iranian families, but outside the GLC3C locus reported in 2002 (22) . The observations suggest that another as yet unidentified PCG causing gene close to LTPB2 on chromosome 14 may exist. Alternatively, the proximal border of GLC3C as originally described may have been incorrectly defined (9) .
LTBP2 contains 36 exons and codes a matrix protein containing 1821 amino acids (23, 24) . On the basis of structural properties, it codes a protein that is a member of a superfamily composed of fibrillins and LTBP proteins (25 -27) . These proteins contain tandem arrays of epidermal growth factor-like motifs, interspersed with characteristic transforming growth factor beta (TGF-b) binding protein (TB)-like motifs (Fig. 3) .
TGF-bs constitute a family of potent multifunctional cytokines that modulate many cellular and physiological processes (28) . TGF-bs exist extracellularly as latent complexes awaiting to be activated by appropriate signals (29) . The storage sites of these complexes are the fibrillin-containing microfibrils (30) . The LTBP proteins are so named because of their ability to bind latent forms of TGF-bs, and there are four LTBP family members (LTBP1-LTBP4) on the basis of structural features. There is no evidence of direct binding of the TGF-bs to fibrillin, and it has been suggested that LTBP proteins that can bind both molecules mediate the interaction between them (31,32). Only LTBP2 among the LTBP proteins does not covalently interact with TGF-b, however, non-covalent interaction of LTBP2 with TGF-bs has not been ruled out (26, 33, 34) .
Although the precise function of LTBP2 remains unknown, there is evidence for LTBP2 having roles in tissue repair processes and in cell adhesion (30, 35, 36) . Notable presence of LTBP2 in elastic tissues and association of this protein with fibrillin containing microfibrils has been demonstrated (34) . LTBP2 interacts via its carboxyl terminal with fibrillin 1 and via its amino terminal with fibulin 5 (32, 37) . These observations suggest that LTBP2 has functions related to those of microfibrils and elastin fibers.
All of the earlier identified mutations in LTBP2 and the p.Ser472fsX3 deletion observed in one of the Iranian families result in truncation of the LTBP2 protein within its amino terminal (Fig. 3 (17) ). These mutations are expected to extensively affect protein structure and function, and interfere with both fibrillin 1 and fibulin 5 binding. However, the p.Tyr1793fsX55 PCG associated deletion observed in Family A exclusively affects the carboxyl terminal of LTBP2, suggesting that interference with fibulin 5 binding alone may be deleterious. Changes in the elasticity properties of the ciliary processes and the trabecular meshwork, where expression of the protein in the human eye was shown, may directly or indirectly affect aqueous fluid outflow, thus contributing to the PCG phenotype.
Mutations in fibrillin 1, a protein with which LTBP2 interacts, cause Marfan syndrome (OMIM 154700) (38 -40) . The syndrome is characterized by skeletal, cardiovascular and optic Human
defects, and the optic defects include ectopia lentis, keratectasia and glaucoma (41) . It is notable that two of the three LTBP2 mutation harboring PCG patients examined were affected with ectopia lentis, and one exhibited keratecasia (Fig. 2) . Ectopia lentis was also observed in some of the LTBP2 mutation harboring PCG patients previously reported (17) . The observation of high expression of LTBP2 in the lens capsule/lens epithelium layer may be relevant to the development of lens displacement in individuals carrying LTBP2 mutations. In any case, it seems appropriate to screen for mutations in LTBP2 in glaucoma patients exhibiting ectopia lentis. Mutations in CYP1B1, a previously known PCG linked gene, has recently been observed in patients affected with primary open angle glaucoma, the more common form of the disease in western populations (42 -44) . As such, it also seems appropriate to assess a possible role for LTBP2 in individuals affected with this condition. In addition, further clarification of the mechanism by which LTBP2 affects PCG status is warranted to elucidate the role of the LTBP2 gene in glaucoma and to contribute to the development of novel therapeutic strategies.
MATERIALS AND METHODS
This research was performed in accordance with the Helsinki Declaration and with approval of the ethics board of the University of Tehran. All participants or their responsible guardians consented to participate after being informed of the nature of the research. Eye globes used to prepare primary trabecular meshwork cell lines or used to prepare histological sections were obtained from the Central Eye Bank of Iran in Tehran. Donors to this bank agree to have their tissues be used for transplantation or research purposes. The trabecular meshwork cell lines were developed using trabecular meshwork extracted from unused portions of globes that had been used in transplantion surgery.
Subjects
Three unrelated Iranian families with affected members suffering from PCG were here examined (Fig. 1 ). CYP1B1 and MYOC had been previously excluded as causative genes in these families by direct sequencing and linkage analysis. Disease inheritance in all the families was consistent with an autosomal recessive pattern of inheritance. The pedigree of family A was large and highly suitable for autozygosity mapping; it consisted of several consanguineous loops, several branches with multiple affected and non-affected siblings, and a total of 10 affected individuals (Fig. 1A) . The family members were all Azeris, from the northwest region of Iran. Family B was a smaller nuclear consanguineous family, consisting of two affected and two non-affected siblings born to non-affected parents (Fig. 1B) . The family was from central Iran (Varamin), and not of Azeri origin. Family C contained one affected child and one non-affected child born to non-affected parents (Fig. 1C) . This family was also Azeri, from the northwest region of Iran. The parents claimed nonconsanguinity, but they belonged to a small highly inbred village. In addition to the affected pedigrees, 400 unrelated healthy Iranians without self reported eye disorders were recruited to serve as controls. Half of the control individuals were Azeris, and the others were Iranians who claimed nonBaluch, non-Kurdish and non-Azeri origins.
Medical examinations
All affected individuals who were not blind at time of recruitment were examined by one of the authors who is a glaucoma specialist (NN). Unfortunately, among the affected individuals only three in pedigree A (individuals 08, 13 and 23) and the affected individual (individual 40) in family C were not blind at time of recruitment. The two affected siblings of individual 04 in family A refrained from providing DNA for the study, but they reported as having been diagnosed with PCG by a glaucoma specialist. Both had become blind in early childhood.
Genotyping and autozygosity mapping
Genome-wide SNP genotyping was carried out on 26 DNA samples belonging to members of the families described using Human370CNV-Quad Infinium HD BeadChips and the iScan reader (Illumina; www.illumina.com). All affected individuals were genotyped except two in pedigree A for whom DNA was not available (Fig. 1) . Twelve non-affected individuals in pedigree A and all non-affected siblings in Families B and C were also genotyped (Fig. 1) . SNPs that had not been genotyped in one or more individual and SNPs that exhibited Mendelian error was removed from the analysis with appropriate options in the BeadStudio v3.2 program (Illumina) (19) . Subsequently, homozygous regions were identified using PLINK v1.02 (45) . Threshold criteria for homozygous regions to be pursued were minimum physical length of 1 Mb, presence of at least 50 homozygous adjacent markers and not more than one heterozygous call. Finally, homozygous regions within chromosome 14 of individuals of families A and B were visualized as regions of loss of heterozygosity as produced by the Homozygosity Detector tool within the BeadStudio program. 
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Gene screening
The NCBI database was used to identify genes within a 4.55 Mb autozygous chromosomal region on chromosome 14 observed to be associated with disease status. Genes were prioritized for mutation screening on the basis of known functions and tissue expression profiles. Exons and flanking intronic sequences of ABCD4, ALDH6A1, ESSRB, LTBP2, TGFB3, TTLL5 and VSX2 were amplified by PCR, and subsequently sequenced using the primers of the PCR reactions. Sequencing was done using ABI Big Dye terminator chemistry and an ABI 3730XL genetic analyzer instrument (Applied Biosystems, Foster city, CA, USA Table S2 .
Expression analysis
Two primary trabecular meshwork cell lines were prepared from trabecular meshwork of donor eye globes (46) . The nature of the cell lines was confirmed by demonstrating increased expression of myocilin upon dexamethasone treatment (not shown) (46, 47) . Transcription of genes encoding actin, FOXC1, CYP1B1 and LTBP2 was shown in these lines by real time PCR (48) . RNA isolation and complementary DNA synthesis were done by standard procedures (49) . Real time PCR was performed on a Corbett 65H0 machine (Australia) using the QuantiFast SYBR Green PCR Kit and gene specific primers (QIAGEN, Germantown, MD, USA; actin primers: Hs_ACTB_2_SG, FOXC1 primers: Hs_FOXC1_2_SG, CYP1B1 primers: Hs_CYP1B1_2_SG, and LTBP2 primers: Hs_LTBP2_1_SG). Expression levels of these genes were compared using software provided by the Corbett instrument. LTBP2 protein expression was assessed in tissue sections prepared from two human globes by immunofluorescence analysis. The globes used for this purpose underwent routine examinations after removal from cadavers, and cryosectioned within 24 h of death. Briefly, sections were incubated with goat polyclonal antibody against human LTBP2 (LTBP-2 (N20), Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), and negative controls were not incubated with primary antibody. They were subsequently incubated with fluorescent conjugated rabbit anti-goat secondary antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA). Nuclei in the same sections were counterstained with DAPI (Invitrogen). The sections were visualized with an Axioplan 2 fluorescence microscope (Carl Zeiss, Germany).
